An economic analysis of prenatal cytogenetic technologies for sonographically detected fetal anomalies.

Abstract

When congenital anomalies are diagnosed on prenatal ultrasound, the current standard of care is to perform G-banded karyotyping on cultured amniotic cells. Chromosomal microarray (CMA) can detect smaller genomic deletions and duplications than traditional karyotype analysis. CMA is the first-tier test in the postnatal evaluation of children with multiple… (More)
DOI: 10.1002/ajmg.a.36435

Topics

  • Presentations referencing similar topics